Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

InterCare DX, Inc.

ICCOPNK
Healthcare
Medical - Healthcare Information Services
$0.00
$0.00(0.00%)
U.S. Market is Open • 14:33

InterCare DX, Inc. Fundamental Analysis

InterCare DX, Inc. (ICCO) shows moderate financial fundamentals with a PE ratio of -0.01, profit margin of 0.00%, and ROE of 16.88%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.00

Areas of Concern

Operating Margin0.00%
Cash Position0.98%
Current Ratio0.00
We analyze ICCO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 58.6/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
58.6/100

We analyze ICCO's fundamental strength across five key dimensions:

Efficiency Score

Weak

ICCO struggles to generate sufficient returns from assets.

ROA > 10%
-10662.16%

Valuation Score

Excellent

ICCO trades at attractive valuation levels.

PE < 25
-0.01
PEG Ratio < 2
-0.00

Growth Score

Weak

ICCO faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

ICCO shows balanced financial health with some risks.

Debt/Equity < 1
-1.00
Current Ratio > 1
0.00

Profitability Score

Weak

ICCO struggles to sustain strong margins.

ROE > 15%
16.88%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is ICCO Expensive or Cheap?

P/E Ratio

ICCO trades at -0.01 times earnings. This suggests potential undervaluation.

-0.01

PEG Ratio

When adjusting for growth, ICCO's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values InterCare DX, Inc. at -0.00 times its book value. This may indicate undervaluation.

-0.00

EV/EBITDA

Enterprise value stands at 0.00 times EBITDA. This is generally considered low.

0.00

How Well Does ICCO Make Money?

Net Profit Margin

For every $100 in sales, InterCare DX, Inc. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $16.88 in profit for every $100 of shareholder equity.

16.88%

ROA

InterCare DX, Inc. generates $-10662.16 in profit for every $100 in assets, demonstrating efficient asset deployment.

-10662.16%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.01 in free cash annually.

$-0.01

FCF Yield

ICCO converts -39.65% of its market value into free cash.

-39.65%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.01

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.00

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.00

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.17

vs 25 benchmark

ROA

Return on assets percentage

-10662.16

vs 25 benchmark

ROCE

Return on capital employed

0.16

vs 25 benchmark

How ICCO Stacks Against Its Sector Peers

MetricICCO ValueSector AveragePerformance
P/E Ratio-0.0128.25 Better (Cheaper)
ROE16.88%780.00% Weak
Net Margin0.00%-20122.00% (disorted) Weak
Debt/Equity-1.000.30 Strong (Low Leverage)
Current Ratio0.004.66 Weak Liquidity
ROA-1066216.22%-14687.00% (disorted) Weak

ICCO outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews InterCare DX, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ